In this interview, Drs. Bas Trietsch from MIMETAS and Jenna Moccia from STEMCELL Technologies explore the use of stem cell-based models in drug discovery. They discuss how regulatory milestones underscore the growing acceptance of these models, prompting scientists to seek out clinically predictive tools such as organoids and organ-on-a-chip systems.

You can learn more about the importance of human-based 3D model systems, their impact on drug discovery, and the future outlook of this technology in the full interview with Jenna and Bas here.